Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 2Breast Neoplasms 2Vascular Diseases 1Rectal Neoplasms 1Precancerous Conditions 1Neurotoxicity Syndromes 1Myocardial Ischemia 1Myocardial Infarction 1Heart Diseases 1Fibrosis 1Fatigue 1Erectile Dysfunction 1Coronary Disease 1Colorectal Neoplasms 1Colonic Neoplasms 1Cerebrovascular Disorders 1Cardiovascular Diseases 1Brain Neoplasms 1Adenomatous Polyps 1

Interventions

Sildenafil Citrate 4Alprostadil 2alpha-Tocopherol 1Vitamin E 1Tacrolimus 1Surveys and Questionnaires 1Pentoxifylline 1Erythropoietin 1Atorvastatin 1Arginine 1ArginMax 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Erectile Dysfunction × Vitamin E × Clear all
NCT03830164 2023-10-17

Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer

M.D. Anderson Cancer Center

Phase 2 Completed
14 enrolled 9 charts

Erectile Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡